ACP is working actively in the field of performance measurement because we recognize its importance in the changing health care environment and want to shape its impact on Internal Medicine. The Performance Measurement Committee oversees the College's activities in this area.
The Performance Measurement Committee applies criteria to assess the validity of performance measures for healthcare. The criteria are evaluated with a modified RAND-UCLA appropriateness method to determine whether they are evidence-based, methodologically sound, and clinically meaningful. This tool has been created to help you filter the reviewed performance measures.
Latest Performance Measurement Committee Papers
ACP develops clinical policy papers and performance measurement commentaries published in scientific journals to educate ACP members about performance measurement initiatives.
- Performance Measures for Physicians Providing Clinical Care Using Telemedicine (Annals of Internal Medicine, 2023)
- Recommending Caution in Patient-Reported Outcome–Based Performance Measurement (Annals of Internal Medicine, 2021)
- Time Out -- Charting a Path for Improving Performance Measurement (New England Journal of Medicine, 2018)
= ACP Supports This Measure
= ACP Does Not Support This Measure: Uncertain Validity
= ACP Does Not Support This Measure
Recent Measure Reviews
- Group/Practice
- Health Plan
- Individual Clinician
Cervical Cancer Screening
Percentage of women 21-64 years of age who were screened for cervical cancer using either of the following criteria:
- Women age 21-64 who had cervical cytology performed within the last 3 years
- Women 30–64 years of age who had cervical high-risk human papillomavirus (hrHPV) testing performed within the last 5 years
- Women age 30-64 who had cervical cytology/high-risk human papillomavirus (hrHPV) cotesting within the last 5 years
Date Reviewed: January 27, 2022
- Individual Clinician
- Group/Practice
- Health Plan
Colorectal Cancer Screening
Percentage of patients 50-75 years of age who had appropriate screening for colorectal cancer.
Date Reviewed: January 27, 2022
- Group/Practice
- Individual Clinician
Age Appropriate Screening Colonoscopy
The percentage of screening colonoscopies performed in patients greater than or equal to 86 years of age from January 1 to December 31.
Date Reviewed: January 27, 2022
- Group/Practice
- Individual Clinician
Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk Patients
Percentage of patients aged 50 to 75 years of age receiving a screening colonoscopy without biopsy or polypectomy who had a recommended follow-up interval of at least 10 years for repeat colonoscopy documented in their colonoscopy report.
Date Reviewed: January 27, 2022
- Health Plan
- Individual Clinician
- Integrated Delivery System
Breast Cancer Screening
Percentage of women 50 - 74 years of age who had a mammogram to screen for breast cancer in the 27 months prior to the end of the measurement period.
Date Reviewed: January 27, 2022
- Group/Practice
- Individual Clinician
Colonoscopy Interval for Patients with a History of Adenomatous Polyps-Avoidance of Inappropriate Use
Percentage of patients aged 18 years and older receiving a surveillance colonoscopy, with a history of prior adenomatous polyp(s) in previous colonoscopy findings, which had an interval of 3 or more years since their last colonoscopy.
Date Reviewed: January 27, 2022